Shen Hongchun, Ming Yao, Xu Chuanlan, Xu Yanwen, Zhao Sha, Zhang Qiong
Department of Nephrology, The Affiliated Traditional Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China.
J Cell Physiol. 2019 Sep;234(9):15123-15133. doi: 10.1002/jcp.28153. Epub 2019 Jan 22.
The objective of this study was to investigate the molecular mechanism of how TUG1 interferes with the expression of C/EBP homologous protein (CHOP), peroxisome-proliferator-activated receptor-γ coactivator-1 alpha (PGC-1α), which contributes to the development of diabetic nephropathy. Real-time polymerase chain reaction and western blot analysis were performed to explore the regulatory relationship among TUG1, CHOP, PGC-1α, and caspase-3. Terminal deoxynucleotidyl transferase dUTP nick-end labeling was performed to confirm TUG1 involved in diabetic nephropathy (DN) through influencing podocytes apoptosis. TUG1 was highly expressed in a cell following treatment with high glucose, and PGC-1α and cleaved caspase-3 levels were much lower, while CHOP level was much higher in high glucose group (HG), furthermore, CHOP inhibited PGC-1α expression. TUG1 negatively regulated CHOP expression, and positively regulated PGC-1α expression. Meanwhile, total caspase-3 level in cell treated with or without HG transfected with CHOP small interfering ribonucleic acid (siRNA), TUG1, and TUG1 siRNA showed no evident difference with their corresponding control, while CHOP siRNA and TUG1 evidently decreased, and TUG1 siRNA remarkably increased cleaved caspase-3 level in HG or normal glucose groups in comparison with corresponding control. TUG1 and PGC-1α levels were much lower, while CHOP level was much higher in participants diagnosed with DN. A higher level of CHOP protein and lower level of PGC-1α were observed in subjects diagnosed with DN. Finally, podocytes apoptosis in the DN group was significantly promoted compared with that in nondiabetic renal disease group. Our current study has suggested for the first time that the long noncoding RNA (lncRNA) TUG1 influenced podocytes apoptosis via mediating endoplasmic reticulum stress (ERS)-CHOP-PGC-1α signaling pathway in HG-induced DN.
本研究的目的是探讨TUG1干扰C/EBP同源蛋白(CHOP)、过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC-1α)表达的分子机制,这有助于糖尿病肾病的发展。采用实时聚合酶链反应和蛋白质印迹分析来探究TUG1、CHOP、PGC-1α和半胱天冬酶-3之间的调控关系。进行末端脱氧核苷酸转移酶dUTP缺口末端标记以证实TUG1通过影响足细胞凋亡参与糖尿病肾病(DN)。高糖处理后的细胞中TUG1高表达,高糖组(HG)中PGC-1α和裂解的半胱天冬酶-3水平低得多,而CHOP水平高得多,此外,CHOP抑制PGC-1α表达。TUG1负向调节CHOP表达,正向调节PGC-1α表达。同时,用CHOP小干扰核糖核酸(siRNA)、TUG1和TUG1 siRNA转染的细胞在有无HG处理的情况下,总半胱天冬酶-3水平与其相应对照无明显差异,而与相应对照相比,CHOP siRNA和TUG1在HG或正常葡萄糖组中明显降低,TUG1 siRNA显著增加裂解的半胱天冬酶-3水平。在诊断为DN的参与者中,TUG1和PGC-1α水平低得多,而CHOP水平高得多。在诊断为DN的受试者中观察到较高水平的CHOP蛋白和较低水平的PGC-1α。最后,与非糖尿病肾病组相比,DN组足细胞凋亡明显增加。我们目前的研究首次表明,长链非编码RNA(lncRNA)TUG1在高糖诱导的DN中通过介导内质网应激(ERS)-CHOP-PGC-1α信号通路影响足细胞凋亡。